The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor

New England Journal of Medicine

Volumn 337, Issue 24, 1997, Pages 1720-1725

  Khurana Hershey, Gurjit K ^a   Friedrich, Michal F ^a   Esswein, Laura A ^a   Thomas, Matthew L ^a   Chatila, Talal A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ARGININE; CD23 ANTIGEN; GLUTAMINE; GUANINE; IMMUNOGLOBULIN E; INTERLEUKIN 4 RECEPTOR; RECEPTOR SUBUNIT;

ADULT; ALLERGY; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; ATOPY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA E; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION;

ADULT; ALLELES; DERMATITIS, ATOPIC; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOBLOTTING; IMMUNOGLOBULIN E; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION;

EID: 0001325237     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199712113372403     Document Type: Article

References (48)

1. Holford-Strevens V, Warren P, Wong C, Manfreda J. Serum total immunoglobulin E levels in Canadian adults. J Allergy Clin Immunol 1984;73: 516-22.
2. Peat JK, Britton WJ, Salome CM, Woolcock AJ. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. III. Effect of exposure to environmental allergens. Clin Allergy 1987;17:291-300.
3. Cline MG, Burrows B. Distribution of allergy in a population sample residing in Tucson, Arizona. Thorax 1989;44:425-31.
4. Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood: a prospective study. N Engl J Med 1990;323:502-7.
5. Young RP, Hart BJ, Merrett TG, Read AF, Hopkin JM. House dust mite sensitivity: interaction of genetics and allergen dosage. Clin Exp Allergy 1992;22:205-11.
6. Peat JK, Tovey E, Toelle BG, et al. House dust mite allergens: a major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996;153:141-6.
7. Zeiger RS. Development and prevention of allergic disease in childhood. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles and practice. 4th ed. Vol. 2. St. Louis: Mosby-Year Book, 1993:1137-71.
8. Huang SK, Marsh DG. Genetics of allergy. Ann Allergy 1993;70:347-58.
9. Meyers DA, Postma DS, Panhuysen CIM, et al. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 1994;23:464-70.
10. Marsh DG, Neely JD, Breazeale DR, et al. Linkage analysis of IL4 and chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-6.
11. Postma DS, Bleecker ER, Amelung PJ, et al. Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995;333:894-900.
12. Marsh DG, Hsu SH, Roebber M, et al. HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med 1982;155:1439-51.
13. Young RP, Dekker JW, Wordsworth BP, et al. HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994;24:431-9.
14. Shirakawa T, Li A, Dubowitz M, et al. Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor. Nat Genet 1994;7:125-9.
15. Bonnefoy JY, Gauchat JF, Lecoanet-Henchoz S, Graber P, Aubry JP. Regulation of human IgE synthesis. Ann N Y Acad Sci 1996;796:59-71.
16. Stavnezer J. Antibody class switching. Adv Immunol 1996;61:79-146.
17. Idzerda RL, March CJ, Mosley B, et al. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990;171:861-73.
18. Galizzi JP, Zuber CE, Harada N, et al. Molecular cloning of a cDNA encoding the human interleukin 4 receptor. Int Immunol 1990;2:669-75.
19. Kondo M, Takeshita T, Ishii N, et al. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 1993;262:1874-7.
20. Russell SM, Keegan AD, Harada N, et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 1993;262:1880-3.
21. Oakes SA, Candotti F, Johnston JA, et al. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 1996;5:605-15.
22. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 1996;271:29265-70.
23. Buckley RH. Disorders of the IgE system. In: Stiehm ER, ed. Immunologic disorders in infants & children. 4th ed. Philadelphia: W.B. Saunders, 1996:409-22.
24. Geha RS, Leung DY. Hyper immunoglobulin E syndrome. Immunodefic Rev 1989;1:155-72.
25. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl 1980;92:44-7.
26. Cookson WOCM, Hopkin JM. Dominant inheritance of atopic immunoglobulin-E responsiveness. Lancet 1988;1:86-8.
27. Donis-Keller H, Dou S, Chi D, et al. Mutations in the RET protooncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2:851-6.
28. Migone TS, Lin JX, Cereseto A, et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 1995;269:79-81.
29. Plas DR, Johnson R, Pingel JT, et al. Direct regulation of ZAP-70 by SHP-I in T cell antigen receptor signaling. Science 1996;272:1173-6.
30. Glantz SA. Primer of biostatistics. 4th ed. New York: McGraw-Hill, 1997.
31. Kirchner SG, Sivit CJ, Wright PF. Hyperimmunoglobulmemia E syndrome: association with osteoporosis and recurrent fractures. Radiology 1985;156:362.
32. Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 1990;62:457-67.
33. Lewis DB, Liggitt HD, Effmann EL, et al. Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci U S A 1993; 90:11618-22.
34. Vercelli D, Jabara HH, Cunningham-Rundles C, et al. Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest 1990;85:1666-71.
35. Ishizaka A, Joh K, Shibata R, et al. Regulation of IgE and IgG4 synthesis in patients with hyper IgE syndrome. Immunology 1990;70:414-6.
36. Defrance T, Aubry JP, Rousset F, et al. Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J Exp Med 1987;165:1459-67.
37. Ryan JJ, McReynolds LJ, Keegan A, et al. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 1996;4:123-32.
38. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL. An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994; 265:1701-6.
39. Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992; 12:2396-405.
40. Yi T, Mui AL, Krystal G, Ihle JN. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 1993;13:7577-86.
41. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995;80:729-38.
42. Chen HE, Chang S, Trub T, Neel BG. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1996;16:3685-97.
43. Paulson RF, Vesely S, Siminovitch KA, Bernstein A. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shpl. Nat Genet 1996;13:309-15.
44. Imani F, Rager KJ, Catipovic B, Marsh DG. Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation: implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J Biol Chem 1997;272:7927-31.
45. Yetter A, Uddin S, Krolewski JJ, Jiao H, Yi T, Platanias LC. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem 1995;270:18179-82.
46. Gelderloos JA, Anderson SM. Over-expression of protein tyrosine phosphatase 1 (PTP1) alters IL-3-dependent growth and tyrosine phosphorylation. Oncogene 1996;13:2367-78.
47. de la Chapelle A, Traskelin AL, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci U S A 1993;90:4495-9.
48. Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 1995;86:15-22.